Newron Pharmaceuticals S.p.A. (0QOI.L)
CHF 8.22
(0.24%)
CHF 8.22
(0.24%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 9.05 Million | 6.09 Million | 5.76 Million | 5.25 Million | 7.03 Million | 4.02 Million |
| Cost of Revenue | - | - | - | 295 Thousand | 1.42 Million | 1.37 Million |
| Gross Profit | 9.05 Million | 6.09 Million | 5.76 Million | 4.96 Million | 5.61 Million | 2.65 Million |
| Operating Expenses | 20.68 Million | 19.67 Million | 17.78 Million | 22.69 Million | 26.81 Million | 19.12 Million |
| Selling, General and Administrative Expenses | 4.06 Million | 7.39 Million | 7.39 Million | 8.47 Million | 10.49 Million | 9.16 Million |
| Research and Development Expenses | 13.15 Million | 12.04 Million | 10.75 Million | 16.32 Million | 22.45 Million | 15.81 Million |
| Other Expenses | 3.47 Million | - | - | - | - | - |
| Cost and Expenses | 20.68 Million | 19.67 Million | 17.78 Million | 22.69 Million | 26.81 Million | 19.12 Million |
| Operating Income | -11.62 Million | -13.3 Million | -12.35 Million | -18.06 Million | -20.89 Million | -14.97 Million |
| Interest Expense | 4.16 Million | 3.94 Million | 2.91 Million | 2.23 Million | 572 Thousand | 56 Thousand |
| Income Tax Expense | 24 Thousand | 21 Thousand | 17 Thousand | 1.38 Million | 45 Thousand | 16 Thousand |
| Earnings before Tax | -16.2 Million | -17.47 Million | -14.88 Million | -19.61 Million | -20.16 Million | -15.01 Million |
| Net Income | -16.22 Million | -17.49 Million | -14.9 Million | -20.99 Million | -20.2 Million | -15.03 Million |
| Earnings Per Share Basic | -0.91 | -0.98 | -0.84 | -1.18 | -1.13 | -0.84 |
| Earnings Per Share Diluted | -0.91 | -0.98 | -0.84 | -1.18 | -1.13 | -0.84 |
| Weighted Average Shares Outstanding | 17.84 Million | 17.84 Million | 17.84 Million | 17.84 Million | 17.84 Million | 17.84 Million |
| Weighted Average Shares Outstanding (Diluted) | 17.84 Million | 17.84 Million | 17.84 Million | 17.84 Million | 17.84 Million | 17.84 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | 0.94 | 0.80 | 0.66 |
| EBIT Margin | -1.31 | -2.18 | -2.14 | -3.42 | -2.96 | -3.67 |
| Profit Margin | -1.79 | -2.87 | -2.59 | -3.99 | -2.87 | -3.74 |
| EBITDA | -11.83 Million | -13.32 Million | -12.31 Million | -17.99 Million | -20.84 Million | -14.78 Million |
| Earnings Before Tax Margin | -1.28 | -2.18 | -2.14 | -3.44 | -2.97 | -3.72 |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 3.4 Million | 3.56 Million | 9.05 Million | 5.49 Million | 3.26 Million | 6.09 Million |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | 3.4 Million | 3.56 Million | 9.05 Million | 5.49 Million | 3.26 Million | 6.09 Million |
| Operating Expenses | 11.09 Million | 10.88 Million | 20.68 Million | 10.44 Million | 10.09 Million | 19.67 Million |
| Selling, General and Administrative Expenses | 4.63 Million | 3.41 Million | - | 4.11 Million | 3.43 Million | - |
| Research and Development Expenses | 6.45 Million | 7.51 Million | - | 5.68 Million | 6.72 Million | - |
| Other Expenses | - | -50 Thousand | - | - | - | - |
| Cost and Expenses | 11.09 Million | 10.88 Million | 20.68 Million | 10.44 Million | 10.09 Million | 19.67 Million |
| Operating Income | -7.68 Million | -7.32 Million | -11.62 Million | -4.3 Million | -6.84 Million | -13.3 Million |
| Interest Expense | - | - | 4.16 Million | - | - | 3.94 Million |
| Income Tax Expense | 13 Thousand | 13 Thousand | 24 Thousand | 11 Thousand | 20 Thousand | 21 Thousand |
| Earnings before Tax | -9.54 Million | -9.26 Million | -16.2 Million | -6.93 Million | -8.83 Million | -17.47 Million |
| Net Income | -9.55 Million | -9.27 Million | -16.22 Million | -6.95 Million | -8.85 Million | -17.49 Million |
| Earnings Per Share Basic | -0.51 | -0.52 | - | -0.39 | -0.50 | - |
| Earnings Per Share Diluted | -0.51 | -0.52 | - | -0.39 | -0.50 | - |
| Weighted Average Shares Outstanding | 18.56 Million | 17.84 Million | 17.84 Million | 17.84 Million | 17.84 Million | 17.84 Million |
| Weighted Average Shares Outstanding (Diluted) | 18.56 Million | 17.84 Million | 17.84 Million | 17.84 Million | 17.84 Million | 17.84 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -2.23 | -2.05 | - | -0.77 | -2.12 | - |
| Profit Margin | -2.81 | -2.60 | -1.79 | -1.27 | -2.71 | -2.87 |
| EBITDA | -7.58 Million | -7.28 Million | - | -4.2 Million | -6.91 Million | - |
| Earnings Before Tax Margin | -2.26 | -2.06 | -1.28 | -0.78 | -2.10 | -2.18 |
HMI
CIFR
3778
1856
TEXELIN
PMOIF